Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 2.22% vs -0.22% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 6.98% vs 44.52% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 13.42% vs 4.47% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -11.83% vs -21.36% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Teva Pharmaceutical Industries Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 2.22% vs -0.22% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -1.08% vs -9.26% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 6.98% vs 44.52% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 253.32% vs -157.16% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 13.42% vs 4.47% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 17.18% vs -28.95% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -11.83% vs -21.36% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 33.63% vs -42.93% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






